Systematic review and meta-analysis: sodium picosulfate/magnesium citrate vs. polyethylene glycol for colonoscopy preparation
Authors:
- 28 January 2016
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 72 (5) , 523-532
Abstract
Previous studies comparing sodium picosulfate/magnesium citrate (SPMC) with polyethylene glycol (PEG) drew inconsistent conclusions. We conducted a meta-analysis to compare the performance of the two agents for colonoscopy preparation. A search of randomized controlled trials (RCTs) up to July 2015 was acquired, using MEDLINE, EMBASE, the Cochrane Library, and Google Scholar. We calculated the pooled estimates of bowel cleanliness, polyp/adenoma detection rate (PDR/ADR), completion of preparation, willingness to repeat identical bowel preparation, and adverse events by using relative risk (RR) with random-effects models. A non-inferiority analysis was performed, comparing SPMC to PEG for bowel cleaning efficacy. A total of 25 RCTs were qualified for analysis. There was no statistically significant difference between the two agents in bowel cleanliness, but the effect direction showed a trend in favor of PEG (RR 0.93; 95 % CI 0.86–1.01, P = 0.07). The non-inferiority analysis demonstrated the non-inferiority of SPMC by retaining at least 90 % of the effect of PEG. Similarly, there was no significant difference between the two agents in PDR (RR 0.94; 95 % CI 0.82–1.08, P = 0.37) and ADR (RR 0.88; 95 % CI 0.74–1.05, P = 0.16). However, a higher proportion of patients were likely to complete SPMC preparation (RR 1.08; 95 % CI 1.04–1.13, P < 0.001) and were willing to repeat SPMC preparation (RR 1.44; 95 % CI 1.25–1.67, P < 0.001). The total number of adverse events was significantly lower in the SPMC group (RR 0.78; 95 % CI 0.66–0.93, P = 0.004). SPMC, with better tolerability and less frequent adverse events, demonstrated non-inferior bowel cleaning efficacy than that of the PEG. Large-scale, well-organized, head-to-head studies are warranted.Keywords
This publication has 41 references indexed in Scilit:
- Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I studyGastrointestinal Endoscopy, 2013
- GRADE Leitlinien: 6. Einschätzung der Qualität der Evidenz – Unzureichende PräzisionZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2012
- Meta‐analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985–2010Alimentary Pharmacology & Therapeutics, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Mechanism of action and toxicities of purgatives used for colonoscopy preparationExpert Opinion on Drug Metabolism & Toxicology, 2010
- Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation qualityGastrointestinal Endoscopy, 2009
- Sodium Picosulfate/Magnesium CitrateDrugs, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- The quest for a more acceptable bowel preparation: comparison of a polyethylene glycol/electrolyte solution and a mannitol/Picolax mixture for colonoscopyPostgraduate Medical Journal, 1995
- Short report: comparison of two orally administered bowel preparations for colonoscopy—polyethylene glycol and sodium picosulphateAlimentary Pharmacology & Therapeutics, 1992